The Molecular Basis for Novel Therapies

Cancer Journal - United States
doi 10.1097/ppo.0b013e3182455187
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Radioiodine-Refractory Thyroid Cancer: Molecular Basis of Redifferentiation Therapies, Management, and Novel Therapies

Cancers
Cancer ResearchOncology
2019English

Retracted: Hepatocellular Carcinoma: Novel Molecular Targets in Carcinogenesis for Future Therapies

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2018English

TRPA1 Channels as Novel Molecular Targets for Anti-Inflammatory Therapies in CF Lung

Postdoc Journal
2016English

Novel Targeted Therapies for Autoimmunity

Current Opinion in Immunology
AllergyImmunology
2009English

Molecular Basis for the Selenocysteine Incorporation

Seibutsu Butsuri
2006English

Molecular Targeted Therapies for Pancreatic Cancer

American Journal of Surgery
MedicineSurgery
2008English

Novel Antiatherosclerotic Therapies

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2019English

Existing and Novel Therapies for Psoriasis

Asian Journal of Pharmaceutical and Clinical Research
PharmacologyPharmaceutical Science
2018English

Molecular Basis for Amyloid- Polymorphism

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy